- Home
- CIO vs LRMR Comparison
CIO vs LRMR Comparison
Compare CIO & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CIO | LRMR |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.5M | 316.6M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | CIO | LRMR |
|---|---|---|
| Price | $6.99 | $3.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | N/A | ★ $16.71 |
| AVG Volume (30 Days) | 347.5K | ★ 1.1M |
| Earning Date | 02-19-2026 | 11-05-2025 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $163,795,000.00 | N/A |
| Revenue This Year | $0.32 | N/A |
| Revenue Next Year | $3.20 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.19 | $1.61 |
| 52 Week High | $7.01 | $5.37 |
Technical Indicators
Market Signals| Indicator | CIO | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 67.11 | 40.19 |
| Support Level | $6.94 | $3.31 |
| Resistance Level | $6.97 | $4.01 |
| Average True Range (ATR) | 0.01 | 0.24 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 90.00 | 10.07 |
Price Performance
Historical ComparisonAbout CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.